Publications by authors named "Phoebe Rich"

Claim this Profile
A
A randomized, double-blind, phase 3 study to compare efficacy, safety, and immunogenicity between DMB-3115 and reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis.
Kamelia Vekovska, Beata Imko-Walczuk, Martin Tichý, Zoe Diana Draelos, Petra Cetkovska, Phoebe Rich

JAAD Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nailing the diagnosis.
Milie M Fang, Lyudmyla Susla, Phoebe Rich

J Osteopath Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern definitions of periungual pigmentation (Hutchinson sign): Results of an expert opinion consensus conference.
Eckart Haneke, Adam I Rubin, Marcel Pasch, Fatih Göktay, Matilde Iorizzo, Phoebe Rich, Bertrand Richert

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.
Eingun James Song, Benjamin Ehst, Brad Glick, George Michael Lewitt, Phoebe Rich

Dermatol Ther (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Richard K. Scher, MD.
Mark Holzberg, Shari R Lipner, Adam I Rubin, Phoebe Rich, C Ralph Daniel

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Practices of Subspecialty Nail Clinics: Results of a Survey of the Members of the Council for Nail Disorders.
Safinaz Soliman, Phoebe Rich, Molly A Hinshaw

Skin Appendage Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tribute to Dr Robert Baran: The grandfather of European onychology.
Mark Holzberg, Boni Elewski, Carlton Ralph Daniel, Nathaniel J Jellinek, Shari R Lipner, Phoebe Rich, Bertrand Richert

J Am Acad Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis.
Andrew Blauvelt, Phoebe Rich, Howard Sofen, Bruce Strober, Joseph F Merola

J Am Acad Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for Onychomycosis.
Steven R Feldman, Tracey C Vlahovic, Warren S Joseph, C Ralph Daniel, Boni Elewski, Phoebe Rich

J Drugs Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.
Robert Bissonnette, Andreas Pinter, Laura K Ferris, Sascha Gerdes, Phoebe Rich

N Engl J Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.
Alexander Egeberg, Lars Erik Kristensen, Luis Puig, Phoebe Rich, Saxon D Smith

J Dermatolog Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B Gordon, Phoebe Rich

Immunotherapy· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study.
Stephen K Tyring, Phoebe Rich, Yayoi Tada, Stefan Beeck, Izabella Messina

Dermatol Ther (Heidelb)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B Gordon, Phoebe Rich

J Am Acad Dermatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
Kristian Reich, Curdin Conrad, Lars Erik Kristensen, Saxon D Smith, Luis Puig, Phoebe Rich

J Dermatolog Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study.
Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong, Isaak Effendy, Waldemar Placek, Phoebe Rich

J Dermatolog Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial.
Kristian Reich, Lars Erik Kristensen, Saxon D Smith, Phoebe Rich, Christophe Sapin

Dermatol Pract Concept· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials.
Boni Elewski, Phoebe Rich, Edward Lain, Jennifer Soung, George Michael Lewitt

J Dermatolog Treat· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists.
Shari R Lipner, Mahmoud Ghannoum, Molly A Hinshaw, Phoebe Rich, Beth S Ruben, Richard K Scher

Skin Appendage Disord· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US.
Shari R Lipner, Warren S Joseph, Tracey C Vlahovic, Richard K Scher, Phoebe Rich

J Drugs Dermatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs.
Gurjit S Kaeley, Lihi Eder, Sibel Zehra Aydin, Phoebe Rich, Catherine J Bakewell

J Rheumatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Consensus on Nail Procedures and Selection of CPT Codes.
Julia O Baltz, Adam Rubin, Chris Adigun, C Ralph Daniel, Molly Hinshaw, Phoebe Rich

Dermatol Surg· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nail Tumors.
Anna Quinn Hare, Phoebe Rich

Dermatol Clin· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Boni E Elewski, John W Baddley, Atul A Deodhar, Marina Magrey, Phoebe A Rich

JAMA Dermatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis.
Phoebe Rich, Orin Goldblum, Damon Disch, Chen-Yen Lin, Joseph F Merola

J Drugs Dermatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis